Catalent to acquire gummy maker Bettera from Highlander Partners for $1 billion in cash

Provided by Dow Jones

Aug 30, 2021 11:10 AM UTC

Catalent Inc. (CTLT) said Monday it has reached an agreement to acquire Bettera Holdings LLC, a maker of gummy, soft chew and lozenges as nutritional supplements, from Highlander Partners LP for $1 billion in cash. Bettera has "broad and difficult-to-replicate expertise" in developing and producing products for nutraceutical, functional, and botanical ingredients, and has four production facilities in the U.S., Catalent said in a statement. The deal is expected to close before year-end and includes most of the roughly 500 employees of Bettera, along with manufacturing and packaging assets. Catalent shares jumped 2.9% in premarket trade and are up 25% in the year to date, while the S&P 500 has gained 20%.

-Ciara Linnane

(END) Dow Jones Newswires

08-30-21 0710ET

Transparency is our policy. Learn how it impacts everything we do.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.

Sponsor Center

How we make money

How we use your personal data

How we approach editorial content